Preferential cytoplasmic localization of p34(cdc2) in recurrent human squamous cell carcinoma after radiotherapy

被引:6
作者
CohenJonathan, E
Toulas, C
Rochaix, P
Bachaud, JM
DalySchveitzer, N
Favre, G
机构
[1] UNIV TOULOUSE 3,DEPT RADIOTHERAPY,EA 2048,F-31052 TOULOUSE,FRANCE
[2] UNIV TOULOUSE 3,LAB ONCOL CELLULAIRE & MOL,EA 2048,F-31052 TOULOUSE,FRANCE
[3] CTR CLAUDIUS REGAUD,INSERM U397,TOULOUSE,FRANCE
[4] CTR CLAUDIUS REGAUD,DEPT HISTOPATHOL,TOULOUSE,FRANCE
关键词
D O I
10.2307/3579333
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Duration of the G(2)-phase delay and arrest after exposure to ionizing radiation is thought to influence radiosensitivity. The kinase activity of the p34(cdc2)-cyclin B complex and the p34(cdc2)-cyclin A complex is implicated in G(2)- to M-phase transition and in G(2)-phase arrest after exposure to ionizing radiation. We analyzed the expression level and the subcellular location of p34(cdc2), cyclin A and cyclin B in head and neck squamous cell carcinoma (SCC) tumors; samples were obtained from patients with locally nonrecurrent and recurrent tumors that had been treated by surgery and radiotherapy. No significant difference was noticed in cyclin A, cyclin B and p34(cdc2) expression. However, we noted a significant preferential cytoplasmic location of p34(cdc2) in recurring tumors compared to the nonrecurring ones (P <0.001). This abnormal location of p34(cdc2) occurs even in primary tumors in patients with recurring tumors, suggesting that a default in the activation of p34(cdc2) kinase could be implicated in clinical radioresistance. (C) 1997 by Radiation Research Society.
引用
收藏
页码:277 / 283
页数:7
相关论文
共 31 条
[1]   INCREASED EXPRESSION OF CYCLIN B1 MESSENGER-RNA COINCIDES WITH DIMINISHED G(2)-PHASE ARREST IN IRRADIATED HELA-CELLS TREATED WITH STAUROSPORINE OR CAFFEINE [J].
BERNHARD, EJ ;
MAITY, A ;
MUSCHEL, RJ ;
MCKENNA, WG .
RADIATION RESEARCH, 1994, 140 (03) :393-400
[2]  
BRISTOW RG, 1994, ONCOGENE, V9, P1527
[3]  
DATTA R, 1992, CELL GROWTH DIFFER, V3, P637
[4]  
ELDEIRY WS, 1994, CANCER RES, V54, P1169
[5]  
Kakino S, 1996, CYTOMETRY, V24, P49, DOI 10.1002/(SICI)1097-0320(19960501)24:1<49::AID-CYTO6>3.0.CO
[6]  
2-D
[7]  
KASTAN MB, 1991, CANCER RES, V51, P6304
[8]  
KHARBANDA S, 1994, CANCER RES, V54, P1412
[9]   WILD-TYPE P53 IS A CELL-CYCLE CHECKPOINT DETERMINANT FOLLOWING IRRADIATION [J].
KUERBITZ, SJ ;
PLUNKETT, BS ;
WALSH, WV ;
KASTAN, MB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (16) :7491-7495
[10]  
LOCK RB, 1992, CANCER RES, V52, P1817